Related Experiment Video

Updated: Mar 22, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.2K

Young people with tumours are tested for genetic mutations

    Nursing Children and Young People
    |April 12, 2016
    PubMed

    Insights

    Leading UK hospitals will offer pediatric cancer patients genetic mutation testing to personalize treatments. This approach aims to improve outcomes for children with cancer by tailoring therapies to individual tumor profiles.

    Area of Science:

    • Oncology
    • Genetics
    • Personalized Medicine

    Background:

    • Pediatric cancer treatment traditionally follows standardized protocols.
    • Advancements in genomic sequencing enable tumor mutation identification.
    • Personalized medicine offers a tailored approach to cancer therapy.

    Discussion:

    • Implementing routine genetic mutation testing in pediatric oncology.
    • The potential for identifying actionable mutations in childhood cancers.
    • Challenges and opportunities in integrating genomic data into clinical practice.

    Key Insights:

    • UK hospitals will provide genetic testing for pediatric cancer patients.
    • Focus on identifying specific genetic mutations within tumors.
    • Aim to personalize cancer treatment strategies for children.

    Outlook:

    • Potential for improved treatment efficacy and reduced side effects.
    • Expansion of precision oncology in pediatric care.
    • Future research directions in pediatric cancer genomics.

    More Related Videos

    Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids06:53

    Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

    Published on: June 8, 2019

    9.3K
    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    8.1K

    Related Concept Videos

    Mutagenicity and Carcinogenicity01:25

    Mutagenicity and Carcinogenicity

    Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
    2.1K
    In vitro Mutagenesis01:16

    In vitro Mutagenesis

    5.5K
    Genetic Screens02:46

    Genetic Screens

    Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
    Forward genetic screens
    Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
    5.9K
    Cancer02:18

    Cancer

    Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
    55.5K
    Mutations01:39

    Mutations

    Overview
    96.0K
    In-vitro Mutagenesis01:16

    In-vitro Mutagenesis

    To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
    17.6K